New DIA Program: Clinical Investigator Education, Training, and Certification Jeffrey W. ShermanW. David Watkins Guest Editorial 01 July 2003 Pages: 257 - 258
Development of a Patient Recruitment Program for Phase 2 Trials in a Biotechnology Company Stacey M. FungEllen SuenHerbert B. Lee Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 259 - 270
The Clinical Data Interchange Standards Consortium Laboratory Model: Standardizing Laboratory Data Interchange in Clinical Trials Susan BassionThe Clinical Data Interchange Standards Consortium Laboratory Data Standards Model Team Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 271 - 281
Feasibility of Using the Med-eMonitor System in the Treatment of Schizophrenia: A Pilot Study Paul E. RuskinJudy Van Der WendeBruce A. Kehr Clinical and Non - Clinical Drug Development 01 July 2003 Pages: 283 - 291
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview Damian J. McEntegart Statistics 01 July 2003 Pages: 293 - 308
Efficiency of General Estimating Equations Estimators of Slopes in Repeated Measurements: Adding Subjects or Adding Measurements? Chul AhnSin-Ho Jung Statistics 01 July 2003 Pages: 309 - 316
An Example of an Unblinded, Third-Party Interim Analysis for Sample Size Re-estimation Simon KirbyScott McBrideLohita Puvanarajan Statistics 01 July 2003 Pages: 317 - 320
The New European Union Good Agricultural and Collection Practice Rules: Are Good Practices Good Enough if They Do Not Result in Batch-to-Batch Consistency? Willem K. Scholten Chemistry, Manufacturing, and Controls 01 July 2003 Pages: 321 - 327
Erratum to: Modeling the probability-cost-profitability architecture of portfolio management in the pharmaceutical industry Andreas Zipfel Erratum 01 July 2003 Pages: 328 - 328
Impact of Disease Management on Cost-Effectiveness of Medicare Spending Joshua CohenCherie Poquetie Public Policy 01 July 2003 Pages: 329 - 339
A Primer on Bioterrorism: Potential Pathogens, Roles of United States Governmental Agencies, and Regulatory Models for Product Development Colleen M. Dovenport Public Policy 01 July 2003 Pages: 341 - 352
